Recombinant HSP90aA1 Protein, His-tagged
Cat.No. : | HSP90aA1-2695 |
Product Overview : | Recombinant HSP90aA1 Protein (Met1-Gly496+Ile698-Asp732) with N-His tag was expressed in E. coli. |
- Specification
- Gene Information
- Related Products
Description : | Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle that is linked to its ATPase activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function. |
Source : | E. coli |
Tag : | N-His |
Form : | Freeze-dried powder |
Molecular Mass : | Predicted Molecular Mass: 62.81 kDa Accurate Molecular Mass: 82 kDa |
Protein length : | Met1-Gly496+Ile698-Asp732 |
Purity : | > 95% |
Applications : | Positive Control; Immunogen; SDS-PAGE; WB. |
Stability : | The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37 centigrade for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition. |
Storage : | Avoid repeated freeze/thaw cycles. Store at 2-8 centigrade for one month. Aliquot and store at -80 centigrade for 12 months. |
Storage Buffer : | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
Reconstitution : | Reconstitute in PBS or others. |
Official Symbol : | HSP90aA1 |
Synonyms : | HSP86; HSP90A; HSP90N; HSPC1; HSPCA; HSPCAL1; HSPCAL4; HSPN; Hsp89; Hsp90; LAP2; Lipopolysaccharide-associated protein 2; Renal carcinoma antigen NY-REN-38 |
Official Symbol : | HSP90aA1 |
Synonyms : | HSP86; HSP90A; HSP90N; HSPC1; HSPCA; HSPCAL1; HSPCAL4; HSPN; Hsp89; Hsp90; LAP2; Lipopolysaccharide-associated protein 2; Renal carcinoma antigen NY-REN-38 |
Products Types
◆ Recombinant Protein | ||
HSP90AA1-350C | Recombinant Cynomolgus Monkey HSP90AA1 Protein, His (Fc)-Avi-tagged | +Inquiry |
HSP90AA1-047H | Recombinant Human HSP90AA1 Protein, N-6×His-tagged | +Inquiry |
HSP90AA1-4349M | Recombinant Mouse HSP90AA1 Protein, His (Fc)-Avi-tagged | +Inquiry |
HSP90AA1-2594R | Recombinant Rat HSP90AA1 Protein, His (Fc)-Avi-tagged | +Inquiry |
HSP90AA1-1246P | Recombinant Pig HSP90AA1 Protein, His-tagged | +Inquiry |
◆ Native Protein | ||
HSP90AA1-14H | Native Hsp90 Protein | +Inquiry |
◆ Lysates | ||
HSP90AA1-5362HCL | Recombinant Human HSP90AA1 293 Cell Lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionHSP90AA1 proteins can participate in regulating the expression and function of inflammatory factors in the inflammatory process, which has an impact on the occurrence and development of inflammatory diseases.
HSP90AA1 proteins can help immune cells fold and activate some important antigens, participate in the immune response process, and have an impact on tumor immunotherapy.
The expression level of HSP90AA1 protein is upregulated in some tumor cells and can serve as a potential tumor biomarker for tumor diagnosis and monitoring.
There is no clear evidence that HSP90AA1 protein can be used as a therapeutic target for inflammatory diseases, but its regulatory role in the inflammatory process may provide new ideas for the development of related therapeutic strategies.
HSP90AA1 proteins can lead to the occurrence and development of tumor drug resistance by stabilizing and protecting some resistance-related proteins, such as ABC transporters.
Inhibitors targeting HSP90AA1 proteins can be developed to interfere with their interactions with other proteins, affecting the growth and survival of tumor cells.
Customer Reviews (3)
Write a reviewThis powerful biological activity of the protein combined with its high purity makes the experimental results extremely reliable.
Application range of this protein is really wide, from the laboratory to the clinic, can see its figure, it is really rare.
Short half-life and high clearance of recombinant proteins enable them to effectively avoid drug accumulation and side effects, and provide a strong guarantee for patient safety.
Ask a Question for All HSP90aA1 Products
Required fields are marked with *
My Review for All HSP90aA1 Products
Required fields are marked with *
Inquiry Basket